Latest Breaking News On - Canadian national prescription drug utilization information system - Page 1 : comparemela.com

An analysis of national Canadian data suggest patients receiving either originator or biosimilar infliximab are at a similar risk of the common adverse event.

Marinag birckLinkedin marinag birckCanadian national prescription drug utilization information systemNational ambulatory care reporting systemInternational conference on pharmacoepidemiologyInternational conferenceTherapeutic risk managementAnnual meetingResearch instituteMcgill university health centreHospital discharge abstract databaseNational ambulatory care reporting